title: How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
authors.affiliation: Recanati-Miller Transplantation Institute, Mount Sinai School of Medicine, New York, USA. myron.schwartz@mssm.edu
authors.forename: Myron
authors.initials: M
authors.lastname: Schwartz
authors.forename: Sasan
authors.initials: S
authors.lastname: Roayaie
authors.forename: Josep
authors.initials: J
authors.lastname: Llovet
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D016031:Liver Transplantation; D012008:Recurrence; D016019:Survival Analysis